Breaking News, Collaborations & Alliances

BIOEMTECH, NorthStar Medical Radioisotopes Reach Agreement for Ac-225 Supply

Customers will have consistent access to the alpha-emitting isotope that is used to develop and evaluate targeted radiotherapeutics.

Author Image

By: Patrick Lavery

Content Marketing Editor

BIOEMTECH has inked a strategic agreement with NorthStar Medical Radioisotopes to supply actinium-225 (Ac-225) for preclinical study usage. NorthStar and BIOEMTECH Backgrounds Northstar is a commercial-stage radiopharmaceutical company based in Beloit, Wisconsin. Meanwhile, BIOEMTECH is an Athens-based contract research organization (CRO) developing high-resolution imaging systems for preclinical and translational research. Among these are positron emission tomography (PET) and single-phot...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters